Fibroblast response to hypoxia: The relationship between angiogenesis and matrix regulation

Journal of Surgical Research

Volumn 84, Issue 2, 1999, Pages 127-133

  Steinbrech, Douglas S ^a   Longaker, Michael T ^a   Mehrara, Babak J ^a   Saadeh, Pierre B ^a   Chin, Gyu S ^a   Gerrets, Rene P ^a   Chau, Dorothy C ^a   Rowe, Norman M ^a   Gittes, George K ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Collagen; Fibroblast; Hypoxia; MMP 3; VEGF; Wound repair

Indexed keywords

ANGIOGENESIS; ARTICLE; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; WOUND HEALING;

EID: 0033563711     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5627     Document Type: Article

References (39)

1. Hunt T. K. Prospective: A retrospective perspective on the nature of wounds. Prog. Clin. Biol. Res. 266:1988;13.
2. Knighton D. R., Silver I. A., Hunt T. K. Regulation of wound-healing angiogenesis - Effect of oxygen gradients and inspired oxygen concentration. Surgery. 90:1981;262.
3. Knighton D. R., Fiegel V. D. Regulation of cutaneous wound healing by growth factors and the microenvironment. Invest. Radiol. 26:1991;604.
4. Falanga V. Growth factors and wound healing. J. Dermatol. Surg. Oncol. 19:1993;711.
5. Falanga V., Martin T. A., Takagi H. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J. Cell Physiol. 157:1993;408.
6. Keck P. J., Hauser S. D., Krivi G. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309.
7. Leung D. W., Cachianes G., Kuang W. J. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306.
8. Connolly D. T., Heuvelman D. M., Nelson R. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1989;1470.
9. Brown L. F., Yeo K., Berse B. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176:1992;1375.
10. Sakuda H., Nakashima Y., Kuriyama S., Sueishi K. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1. Am. J. Pathol. 141:1992;1507.
11. Chvapil M., Hurych J., Ehrlichova E. The influence of various oxygen tensions upon proline hydroxylation and the metabolism of collagenous and non-collagenous proteins in skin slices. Hoppe Seylers Z. Physiol. Chem. 349:1968;211.
12. Hunt T. K., Pai M. P. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg. Gynecol. Obstet. 135:1972;561.
13. Jonsson K., Jensen J. A., Goodson W. H. Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann. Surg. 214:1991;605.
14. Prockop D. J., Kivirikko K. I., Tuderman L., Guzman N. A. The biosynthesis of collagen and its disorders (first of two parts). N. Engl. J. Med. 301:1979;13.
15. Brenner C. A., Adler R. R., Rappolee D. A. Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev. 3:1989;848.
16. Matrisian L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121.
17. Di Girolamo N., Lloyd A., McCluskey P. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am. J. Pathol. 150:1997;653.
18. Minchenko A., Bauer T., Saleda S., Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest. 71:1994;374.
19. Mehrara B., Rowe N., Steinbrech D. Rat mandibular distraction osteogenesis. Part II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. Plast. Reconstr. Surg. 103:1999;536.
20. Adair T. H., Gay W. J., Montani J. P. Growth regulation of the vascular system: Evidence for a metabolic hypothesis. Am. J. Physiol. 259:1990;R393.
21. Thomas K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271:1996;603.
22. Sandner P., Wolf K., Bergmaier U. Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitro. Kidney Int. 51:1997;448.
23. Namiki A., Brogi E., Kearney M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270:1995;31189.
24. Enholm B., Paavonen K., Ristimaki A. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene. 14:1997;2475.
25. Detmar M., Brown L. F., Berse B. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Derm. 108:1997;263.
26. Stein I., Neeman M., Shweiki D. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell Biol. 15:1995;5363.
27. Goldberg M., Schneider T. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269:1994;4355.
28. Semenza G. L., Wang G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12:1992;5447.
29. Udenfriend S. Formation of hydroxyproline in collagen. Science. 152:1966;1335.
30. Angel M. F., Ramasastry S. S., Swartz W. M. The causes of skin ulcerations associated with venous insufficiency: A unifying hypothesis. Plast. Reconstr. Surg. 79:1987;289.
31. Falanga V., Moosa H. H., Nemeth A. J. Dermal pericapillary fibrin in venous disease and venous ulceration. Arch. Dermatol. 123:1987;620.
32. Girard M. T., Matsubara M., Kublin C. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J. Cell Sci. 104:1993;1001.
33. Mignatti P., Rifkin D., Welgus H., Parks W. Proteinases and tissue remodeling. Clark R. The Molecular and Cellular Biology of Wound Repair. 1996;427 Plenum, New York.
34. Diaz-Meco M. T., Quinones S., Municio M. M. Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene, and phosphatidylcholine-hydrolyzing phospholipase C [published erratum appears in J. Biol. Chem. 269(2): 1565, 1994]. J. Biol. Chem. 266:1991;22597.
35. Quinones S., Saus J., Otani Y. Transcriptional regulation of human stromelysin. J. Biol. Chem. 264:1989;8339.
36. Saarialho-Kere U. K., Pentland A. P., Birkedal-Hansen H. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J. Clin. Invest. 94:1994;79.
37. Delany A. M., Brinckerhoff C. E. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J. Cell Biochem. 50:1992;400.
38. Mauviel A., Kahari V. M., Kurkinen M. Leukoregulin, a T-cell derived cytokine, upregulates stromelysin-1 gene expression in human dermal fibroblasts: Evidence for the role of AP-1 in transcriptional activation. J. Cell Biochem. 50:1992;53.
39. Mesri E., Federoff H., Brownlee M. Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. Circ. Res. 76:1995;161.